Table 1 Baseline characteristics of the study participants, by procedure
Patient characteristic | ESG N = 16 | LSG N = 45 |
|---|---|---|
Age, mean (SD), years | 41.4 (10.4) | 40.4 (9.0) |
Sex, n (%) female | 13 (81.2) | 38 (84.4) |
Ethnicity, n (%) | ||
 Caucasian | 12 (75) | 40 (89) |
 Asian | 2 (12) | 0 (0) |
 African | 0 (0) | 1 (2) |
 Other | 1 (6) | 0 (0) |
 Not-disclosed | 1 (6) | 2 (4) |
Area of residence, n (%) | ||
 Metropolitan | 14 (88) | 44 (98) |
 Rural | 2 (12) | 1 (2) |
BMI, kg/m2, mean | 35.5 (5.2) | 40.7 (5.6) |
 BMI < 35, n (%) | 9 (56.3) | 6 (13.3) |
 BMI 35- < 50, n (%) | 7 (43.8) | 37 (82.2) |
 BMI ≥50, n (%) | 0 (0) | 2 (4.4) |
Body compositiona, mean (SD) | ||
 Fat mass, kg | 48.5 (8.7) | 57.9 (13.3) |
 Fat-free mass, kg | 49.7 (9.9) | 53.1 (9.7) |
 Bone mineral content, kg | 2.8 (0.3) | 2.8 (0.5) |
SBP (mmHg)b | 129.3 (12.4) | 123.3 (15.1) |
DBP (mmHg)b | 87.6 (9.2) | 83.2 (10.2) |
Type 2 Diabetes Mellitus, n (%) | 0 (0) | 2 (4) |
Hypertension, n (%) | 7 (44) | 14 (31) |
Dyslipidemia, n (%) | 3 (19) | 7 (16) |
Obstructive sleep apnea, n (%) | 0 (0) | 6 (13) |
Osteoarthritis/joint pain, n (%) | 8 (50) | 33 (73) |
Non-alcoholic fatty liver disease, n (%) | 1 (6) | 3 (7) |
Polycystic ovary syndrome (females only), n (%) | 1 (6) | 8 (18) |
Gastroesophageal reflux disease, n (%) | 4 (25) | 17 (38) |
Depression or anxiety, n (%) | 7 (44) | 17 (38) |
Gestational diabetes mellitus (females only), n (%) | 2 (12) | 6 (13) |
Back pain, n (%) | 10 (62) | 31 (69) |
Asthma, n (%) | 3 (19) | 16 (36) |
HSI scorec, mean (SD) | 46.8 (6.3) | 52.8 (6.7) |
Risk of NAFLDd | 15 (94) | 44 (100) |